Literature DB >> 10940924

Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments.

D M Fernandes1, L Vidard, K L Rock.   

Abstract

We evaluated the capacity of the secretory pathway or of different endocytic compartments in B cell lines to generate MHC class II-presented peptides from the antigen ovalbumin (OVA). Sorting signals from the transferrin receptor (TFR), targeted a chimeric OVA fusion protein to early endosomes and led to the generation of 8 of 12 presented peptides. Sorting signals from the lysosome-associated membrane protein 1 (LAMP-1), targeted an OVA fusion protein to lysosomes, and led to the generation of 9 of 12 peptides. In contrast, OVA with only a signal sequence led to the generation of only 2 presented peptides. There were both qualitative and quantitative differences in the generation of peptides from the different fusion proteins, suggesting that multiple distinct compartments are involved in generating different epitopes. One peptide was presented better from the TFR fusion protein, while all others were presented better from the LAMP-1 construct. Twelve peptides were generated from exogenously supplied OVA, including 3 peptides that were not generated from any of the fusion proteins. Since most endogenously synthesized foreign antigens are rarely presented on class II molecules, these studies further suggest a strategy whereby antigens in DNA-based vaccines could be targeted to endocytic compartments to enhance immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940924     DOI: 10.1002/1521-4141(2000)30:8<2333::AID-IMMU2333>3.0.CO;2-F

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Cellular protein is the source of cross-priming antigen in vivo.

Authors:  Lianjun Shen; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

2.  Development and Characterization of an HCMV Multi-Antigen Therapeutic Vaccine for Glioblastoma Using the UNITE Platform.

Authors:  Amit S Adhikari; Juliete Macauley; Yoshimi Johnson; Mike Connolly; Timothy Coleman; Teri Heiland
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

3.  Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression.

Authors:  Barry A Kriegsman; Pranitha Vangala; Benjamin J Chen; Paul Meraner; Abraham L Brass; Manuel Garber; Kenneth L Rock
Journal:  J Immunol       Date:  2019-08-30       Impact factor: 5.422

4.  MHC class II presentation of gp100 epitopes in melanoma cells requires the function of conventional endosomes and is influenced by melanosomes.

Authors:  Valentina Robila; Marina Ostankovitch; Michelle L Altrich-Vanlith; Alexander C Theos; Sheila Drover; Michael S Marks; Nicholas Restifo; Victor H Engelhard
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

5.  Prolonged antigen presentation following an acute virus infection requires direct and then cross-presentation.

Authors:  Erica L Heipertz; Michael L Davies; Eugene Lin; Christopher C Norbury
Journal:  J Immunol       Date:  2014-09-15       Impact factor: 5.422

6.  Human immunodeficiency virus type 1 endocytic trafficking through macrophage bridging conduits facilitates spread of infection.

Authors:  Irena Kadiu; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

7.  Expression of the Receptor Tyrosine Kinase EphB2 on Dendritic Cells Is Modulated by Toll-Like Receptor Ligation but Is Not Required for T Cell Activation.

Authors:  Patrice N Mimche; Lauren M Brady; Shirley Keeton; David S J Fenne; Thayer P King; Kendra M Quicke; Lauren E Hudson; Tracey J Lamb
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

8.  Efficient Presentation of Multiple Endogenous Epitopes to Both CD4+ and CD8+ Diabetogenic T Cells for Tolerance.

Authors:  Shamael R Dastagir; Jorge Postigo-Fernandez; Chunliang Xu; James H Stoeckle; Rebuma Firdessa-Fite; Rémi J Creusot
Journal:  Mol Ther Methods Clin Dev       Date:  2016-12-24       Impact factor: 6.698

9.  Natural cathepsin E deficiency in the immune system of C57BL/6J mice.

Authors:  Calogero Tulone; Jhen Tsang; Zofia Prokopowicz; Nicholas Grosvenor; Benny Chain
Journal:  Immunogenetics       Date:  2007-11-14       Impact factor: 3.330

10.  HER2-LAMP vaccines effectively traffic to endolysosomal compartments and generate enhanced polyfunctional T cell responses that induce complete tumor regression.

Authors:  Alan Chen Chen; Renhuan Xu; Tao Wang; Junping Wei; Xiao-Yi Yang; Cong-Xiao Liu; Gangjun Lei; Herbert Kim Lyerly; Teri Heiland; Zachary Conrad Hartman
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.